Skip to main content

(Approval lapsed) Atenolol Oral Solution 25mg/5mL (Cresent)

Section 19A approved medicine
(Approval lapsed) Atenolol Oral Solution 25mg/5mL (Cresent)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
Atenolol-AFT atenolol 50 mg/10 mL oral solution bottle- ARTG 184745
Indication(s)
  • All grades of hypertension, including hypertension of renal origin.
  • Frequent disabling angina without evidence of cardiac failure.
  • Cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction).
  • Myocardial infarction - Late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain).

Help us improve the Therapeutic Goods Administration site